|
Model Number OP-05D |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Urticaria (2278)
|
Event Date 03/29/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
The product of this event was not returned to the manufacturer and could not be analyzed; however, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and not similar event has been reported with this lot number globally so far.The physician determined, this event as "non-serious injury" and the cause of the urticaria may have been due to use of fresh frozen plasma, but causal relationship between urticaria and the use of the medical device cannot be denied.We consider this event as "serious injury" since it was a systemic urticaria and medications are being administered via iv as a treatment.Although fresh frozen plasma may be the cause of the urticaria, the causal relationship between the urticaria and the use of the medical device cannot be denied because it occurred during the use of the medical device.Urticaria is described as one of the adverse events in "e.Precautions" of ifu.We will continue to monitor the occurrence of similar events carefully.
|
|
Event Description
|
This incident occurred in japan.Plasmaflo op-d series is identical model to op-05w(a) marketed in us.Patient with multiple sclerosis received plasmaapheresis therapy using op-05d.Fresh frozen plasma was used for replacement fluid.After completion of plasmapheresis therapy on (b)(6) 2024, itchy urticaria was developed.The areas where the urticaria occurred were the face, neck, both hands, part of the upper arm, and the left groin.After administering 1 vial of d-chlorpheniramine maleate and 125mg of methylprednisolone sodium succinate via iv, the patient's condition gradually improved and recovered within the same day.
|
|
Search Alerts/Recalls
|
|
|